Characterization of a clonal human colon adenocarcinoma line intrinsically resistant to doxorubicin

被引:30
作者
Dolfini, E
Dasdia, T
Arancia, G
Molinari, A
Calcabrini, A
Scheper, RJ
Flens, MJ
Gariboldi, MB
Monti, E
机构
[1] UNIV MILAN,INST PHARMACOL,APPL PHARMACOL SECT,I-20129 MILAN,ITALY
[2] UNIV MILAN,DEPT BIOL & GENET HLTH SCI,I-20133 MILAN,ITALY
[3] IST SUPER SANITA,DEPT ULTRASTRUCT,I-00161 ROME,ITALY
[4] FREE UNIV AMSTERDAM HOSP,DEPT PATHOL,NL-1081 HV AMSTERDAM,NETHERLANDS
关键词
intrinsic drug resistance; doxorubicin; colon adenocarcinoma; multidrug resistance-associated protein; lung resistance-related protein;
D O I
10.1038/bjc.1997.338
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Intrinsic low-level resistance to anti-cancer drugs is a major problem in the treatment of gastrointestinal malignancies. To address the problem presented by intrinsically resistant tumours, we have isolated two monoclonal lines from LoVo human colon adenocarcinoma cells: LoVo/C7, which is intrinsically resistant to doxorubicin (DOX); and LoVo/C5, which shows the same resistance index for DOX as the mixed parental cell population. For comparison, we have included in the study a LoVo-resistant line selected by continuous exposure to DOX and expressing a typical multidrug resistant (MDR) phenotype. In these cell lines we have studied the expression and/or activity of a number of proteins, including P-glycoprotein 170 (P-gp), multidrug resistance-associated protein (MRP), lung resistance-related protein (LRP), glutathione (GSH)-dependent enzymes and protein kinase C (PKC) isoforms, which have been implicated in anti-cancer drug resistance. Intracellular DOX distribution has been assessed by confocal microscopy. The results of the present study indicate that resistance in LoVo/C7 cells cannot be attributed to alterations in P-gp, LRP or GSH/GSH-dependent enzyme levels. Increased expression of MRP, accompanied by alterations in the subcellular distribution of DOX, has been observed in LoVo/C7 cells; changes in PKC isoform pattern have been detected in both intrinsically and pharmacologically resistant cells.
引用
收藏
页码:67 / 76
页数:10
相关论文
共 38 条
  • [1] AHMAD S, 1993, MOL PHARMACOL, V43, P858
  • [2] ALLEY MC, 1988, CANCER RES, V48, P589
  • [3] BECK WT, 1987, CANCER RES, V47, P5455
  • [4] BLOBE GC, 1993, J BIOL CHEM, V268, P658
  • [5] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [6] CHAUDHARY PM, 1992, ONCOL RES, V4, P281
  • [7] CIANFRIGLIA M, 1994, INT J CANCER, V56, P153
  • [8] OVEREXPRESSION OF A TRANSPORTER GENE IN A MULTIDRUG-RESISTANT HUMAN LUNG-CANCER CELL-LINE
    COLE, SPC
    BHARDWAJ, G
    GERLACH, JH
    MACKIE, JE
    GRANT, CE
    ALMQUIST, KC
    STEWART, AJ
    KURZ, EU
    DUNCAN, AMV
    DEELEY, RG
    [J]. SCIENCE, 1992, 258 (5088) : 1650 - 1654
  • [9] DIFFERENT VIMENTIN EXPRESSION IN 2 CLONES DERIVED FROM A HUMAN COLOCARCINOMA CELL-LINE (LOVO) SHOWING DIFFERENT SENSITIVITY TO DOXORUBICIN
    CONFORTI, G
    CODEGONI, AM
    SCANZIANI, E
    DOLFINI, E
    DASDIA, T
    CALZA, M
    CANIATTI, M
    BROGGINI, M
    [J]. BRITISH JOURNAL OF CANCER, 1995, 71 (03) : 505 - 511
  • [10] Regulation of P-glycoprotein 1 and 2 gene expression and protein activity in two MCF-7/Dox cell line subclones
    Davies, R
    Budworth, J
    Riley, J
    Snowden, R
    Gescher, A
    Gant, TW
    [J]. BRITISH JOURNAL OF CANCER, 1996, 73 (03) : 307 - 315